Evicenter
MarkdownMedical informationP&T meetings
Palazestrant (OP-1250)

Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Manufacturer
Olema Oncology
Last updated
256 sources

Product information and disease descriptionProduct descriptionProduct information

Special populations

9 evidence topics · 8 sources

Nonclinical reproductive and developmental toxicology

No evidence found.

Hepatic and renal impairment: dedicated pharmacokinetic studies

No evidence found.

Central nervous system metastases: phase 2 cohort and exclusion from OPERA-01